These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A; JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543 [TBL] [Abstract][Full Text] [Related]
8. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and long-term outcomes after drug-eluting stent implantation. Alfonso F JAMA; 2007 Apr; 297(16):1769; author reply 1770-1. PubMed ID: 17456814 [No Abstract] [Full Text] [Related]
10. Does clopidogrel each day keep stent thrombosis away? Kereiakes DJ JAMA; 2007 Jan; 297(2):209-11. PubMed ID: 17213405 [No Abstract] [Full Text] [Related]
11. Clopidogrel and long-term outcomes after drug-eluting stent implantation. Falcone EL; Tangri N JAMA; 2007 Apr; 297(16):1770; author reply 1770-1. PubMed ID: 17456815 [No Abstract] [Full Text] [Related]
12. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. Eisenstein EL; Anstrom KJ; Kong DF; Shaw LK; Tuttle RH; Mark DB; Kramer JM; Harrington RA; Matchar DB; Kandzari DE; Peterson ED; Schulman KA; Califf RM JAMA; 2007 Jan; 297(2):159-68. PubMed ID: 17148711 [TBL] [Abstract][Full Text] [Related]
13. The excel stent: a good DES, but can we really stop clopidogrel after 6 months? Margolis JR JACC Cardiovasc Interv; 2009 Apr; 2(4):310-1. PubMed ID: 19463442 [No Abstract] [Full Text] [Related]
14. Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Iakovou I; Antoniucci D; Grube E; Tamburino C; Di Mario C; Reimers B; Michev I; Goktekin O; Airoldi F; Chieffo A; Cosgrave J; Tassanawiwat W; Colombo A; Int J Cardiol; 2006 Apr; 108(3):406-7. PubMed ID: 16520130 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet therapy in the era of percutaneous coronary intervention with drug-eluting balloons. Bonaventura K; Sonntag S; Kleber FX EuroIntervention; 2011 May; 7 Suppl K():K106-11. PubMed ID: 22027718 [TBL] [Abstract][Full Text] [Related]
16. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system. Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357 [TBL] [Abstract][Full Text] [Related]
17. Comparison of cilostazol and clopidogrel after successful coronary stenting. Lee SW; Park SW; Hong MK; Lee CW; Kim YH; Park JH; Kang SJ; Han KH; Kim JJ; Park SJ Am J Cardiol; 2005 Apr; 95(7):859-62. PubMed ID: 15781016 [TBL] [Abstract][Full Text] [Related]
18. Aneurysm formation after drug-eluting balloon treatment of drug-eluting in-stent restenosis: first case report. Vassilev D; Hazan M; Dean L Catheter Cardiovasc Interv; 2012 Dec; 80(7):1223-6. PubMed ID: 22419657 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes. Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R; JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441 [TBL] [Abstract][Full Text] [Related]
20. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation. Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]